Presented in six separate booklets, the World Drug Report 2020 provides a wealth of information and analysis to support the international community in implementing operational recommendations on a number of commitments made by Member States, including the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem, held in 2016.
European Drug Report 2020
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
What do the latest data tell us about drug production and trafficking trends?
CCSA is the go-to place in Canada for trusted information on COVID-19 and substance use.
In response to threat posed by COVID- 19, they have put together a collection of resources from websites and organizations from around the world.
In this CCSA panel discussion webinar, experts will provide federal, provincial and local perspectives on the response to substance use and mental health during the COVID-19 pandemic. They will explore the implications of the pandemic response on substance use and mental health, as well as the response measures that were taken, lessons learned and recommendations as pandemic restrictions across Canada begin to lift.
2020 OSCE-wide Conference on Combating the Threat of Illicit Drugs and the Diversion of Chemical Precursors
Strengthening Effective Prevention of Drug Use among Youth through Community Policing
Prevention Talk # 1 - A Culture of Prevention: What does that mean and how would it affect research and practice?
About the Event
A recent commentary in Prevention Science, [Sloboda, Z., David, S.B. Commentary on the Culture of Prevention. Prev Sci (2020). https://doi.org/10.1007/s11121-020-01158-8 ] explored the concept of a culture of prevention and what that means to research and practice. The commentary was requested by the Associate Editors of a Special Issue on the topic.
This report provides a review of the research and literature relating to structural stigma in health-care contexts, including how it affects people living with mental health and substance use issues, how it is expressed in the health-care system, and how it can be reduced.
The project is supported by Mental Health Commission of Canada.
Prisons and jails are the largest behavioural health treatment institutions/organizations in every state, and often, especially for those with substance use disorders and mental health conditions, jail or prison are the entry points to Behavioral Health treatment. Once individuals with substance use disorders are released from prison, they have a greater risk of disrupted behavioural health treatment and even fatal overdose.
The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance use disorders (SUD) are at risk population for contamination due to multiple factors—attributable to their clinical, psychological and psychosocial conditions.
When an individual smokes a cigarette (or roll-up, pipe or cigar), most of the smoke doesn't go into their lungs, it goes into the air around them where anyone nearby can breathe it in. This is known as second-hand smoke.
Infants and children are particularly vulnerable to the negative impact of smoke.